Does insurance cover TMS?
Does insurance cover TMS?
If you're researching TMS and wondering whether your insurance will cover it, the short answer is: probably yes for traditional six-week TMS, for depression, if you meet your plan's criteria.
But insurance coverage for TMS is more complicated than that one-sentence answer suggests. And for many patients, the "covered" option turns out to be less financially straightforward and meaningfully less effective than the cash-pay accelerated alternatives. This article is going to walk through all of it honestly, including the math most clinic websites don't show you.
What insurance actually cares about
The "Six-Week" barrier
The math of accelerated TMS vs. traditional insurance
Why we refuse to let insurance dictate your clinical care
What this means for your timeline and options
The short answer: yes, most major insurance plans cover TMS
Traditional repetitive TMS (rTMS) received FDA clearance for major depressive disorder in 2008. In the years since, coverage has expanded significantly. Most major commercial insurance plans including Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, and Humana cover TMS for depression under certain conditions. Medicare covers it. Many Medicaid plans cover it.
If you have insurance and you're considering TMS for depression, there is a reasonable chance your plan covers the traditional six-week protocol. That's the honest starting point.
But "covered" is doing a lot of work in that sentence, and it's worth unpacking what it actually means.
What "covered" actually means in practice
Insurance coverage for TMS typically comes with several conditions attached. Understanding them upfront prevents surprises later.
Prior authorization is almost always required. Before your insurance will approve TMS, your provider needs to submit documentation demonstrating medical necessity. This typically includes your diagnosis, a history of prior treatment attempts, and clinical justification for TMS as the appropriate next step. The prior authorization process can take days to weeks, and it can be denied sometimes requiring appeal.
Prior antidepressant trials are usually required. Most plans require documentation that you have tried and failed to respond adequately to one or more antidepressants before they will approve TMS. The specific number varies by plan. Some require one trial, others require four. If you haven't tried medication, some plans won't cover TMS regardless of your circumstances.
Coverage is typically limited to depression. Most insurance plans that cover TMS cover it specifically for major depressive disorder. Coverage for OCD is available through some plans following the 2018 FDA clearance for deep TMS. Coverage for anxiety and PTSD varies significantly and is often not covered as a primary TMS indication.
Accelerated protocols are generally not covered. This is the most important thing to understand if you're considering our one-day or five-day intensive options: most insurance plans do not currently cover accelerated TMS protocols. These are cash-pay. We can pursue single-case authorization agreements in appropriate circumstances, but we don't want you to plan your finances around that outcome.
[Contact us to verify your specific coverage →]
The real cost of "covered" TMS the math worth doing
Here's where the picture gets more interesting. When patients hear that traditional TMS is "covered by insurance," the natural assumption is that it will be significantly cheaper than a cash-pay alternative. That assumption is worth pressure-testing.
Traditional TMS involves 36 sessions delivered once per day, five days per week, for six weeks. Let's look at what that actually costs out of pocket under a few common scenarios.
The co-pay scenario: Many commercial plans cover TMS with a specialist co-pay per visit. At a typical specialist co-pay of $40–$60 per session:
$40 co-pay × 36 sessions = $1,440 minimum | $60 co-pay × 36 sessions = $2,160 minimum
And that's before your deductible. If your plan has a deductible you haven't met, the early sessions may be billed at the full negotiated rate often $200–$400 per session until you hit your deductible, after which co-pays kick in. A patient with a $1,500 deductible who hasn't met it could easily spend $3,000–$4,000 on a "covered" course of traditional TMS.
The coinsurance scenario: Some plans use coinsurance rather than co-pays for specialist services meaning you pay a percentage of the allowed amount per session rather than a flat fee. At 20% coinsurance on a $300 allowed amount per session:
20% × $300 × 36 sessions = $2,160
Again, before deductible.
The time and transportation cost: This is rarely factored in but matters significantly. Thirty-six visits over six weeks means six weeks of daily clinic trips. For a patient who drives 20 minutes each way, that's approximately 24 hours of travel time across the course of treatment. For patients who need to arrange childcare, take time off work, or travel longer distances, the indirect cost is real and substantial.
For comparison, our cash-pay accelerated options: 1-Day Intensive: $2,995 one clinic visit, complete 5-Day Intensive: $7,995 five consecutive days, complete
In-house payment plans are available for both. The total cost is fixed and known upfront. There are no deductibles, no prior authorization delays, no co-pay accumulation surprises, and no six weeks of schedule disruption.
The 1-Day Intensive at $2,995 compares favorably to most realistic insurance out-of-pocket scenarios once deductibles and co-pays are factored in. The 5-Day Intensive at $7,995 costs more in absolute terms but the efficacy data behind it tells a different story, which brings us to the comparison that matters most.
Insurance plans, deductibles, and out-of-pocket costs vary significantly by plan. These are illustrative examples, not guarantees. Contact us to discuss your specific situation before making a financial decision.
[Schedule a free consultation to review your coverage →]
The efficacy question: what does the research actually show?
Cost comparisons only tell part of the story. The other part is what you're getting for your money and here the data is striking.
Traditional rTMS has been studied extensively since its FDA clearance in 2008. Real-world published response rates for traditional once-daily rTMS for depression are approximately 50–60%, with remission rates around 30–35%. These are meaningful numbers for roughly one in three patients, traditional TMS produces remission. That's a real and valuable outcome.
But accelerated protocols tell a substantially different story.
The Stanford SAINT protocol the five-session-per-day, five-day protocol on which our Five-Day Intensive is modeled, was published in JAMA Psychiatry in 2022. The randomized controlled trial reported a 78.6% remission rate in the active treatment group, compared to 13.3% in the sham group. Mean time to remission was 2.6 days. These results were in a treatment-resistant population patients who had already failed multiple prior treatments.
The ONE-D study. the single-day, 20-session protocol on which our One-Day Intensive is modeled, was published in 2025. It reported an 87.5% response rate and 71.9% remission rate at six weeks, with 84.4% sustained response at 12 weeks. Again, in a treatment-resistant population.
These aren't incremental improvements over traditional TMS. They represent a fundamentally different efficacy profile and the mechanistic reason for that difference is now better understood. Accelerated protocols deliver multiple sessions within a neuroplasticity window, compounding the effects of each session rather than starting from baseline with each daily visit. Traditional once-daily TMS misses that window almost entirely.
What this means practically: a patient who pays $2,160 out of pocket for traditional TMS and achieves the average real-world outcome has roughly a 30–35% chance of remission. A patient who pays $2,995 for the One-Day Intensive has roughly a 72% chance of remission based on published data. A patient who pays $7,995 for the Five-Day Intensive has roughly a 79% chance.
The numbers are not small differences. And cost per remission, a metric rarely discussed on clinic websites but meaningful when you think about it, may actually favor the accelerated options despite their higher sticker price.
What about patients who genuinely can't afford cash-pay?
This is a real and important question, and we want to answer it honestly rather than brush past it.
For patients whose insurance covers traditional TMS and whose true out-of-pocket costs are low patients on plans with minimal deductibles, low co-pays, and no prior authorization complications traditional TMS through insurance may genuinely be the most financially accessible path. We offer traditional TMS with insurance, and we'll help you navigate the prior authorization process.
For patients who are drawn to the accelerated options but concerned about the upfront cost, we offer in-house payment plans on both the One-Day and Five-Day Intensive protocols. We'd rather work with you to make an effective treatment accessible than watch you default to a less effective option for purely financial reasons.
And for patients who are uncertain, a free consultation will give you a clear picture of what your insurance actually covers, what your realistic out-of-pocket costs look like under each scenario, and which protocol our providers think is the best clinical fit for your situation. That conversation costs nothing and commits you to nothing.
Single-case authorization: we'll make the case to your insurance when it's worth making
There is one more option worth knowing about, and most TMS clinics won't mention it because most don't pursue it.
In some circumstances, insurance plans that don't routinely cover accelerated TMS protocols will consider coverage on a case-by-case basis through a process called single-case authorization sometimes also called a single-case agreement or SCA. This involves submitting a formal request to your insurer that presents your specific clinical situation alongside the published evidence supporting accelerated TMS as the most appropriate treatment for you.
We have pursued single-case authorizations for patients whose clinical history makes a compelling case typically patients with treatment-resistant depression, documented prior treatment failures, and circumstances where the accelerated format is medically preferable to a six-week daily protocol. In some of those cases, insurance has agreed to cover the accelerated course.
We want to be honest with you about what this means and doesn't mean:
It is not a reliable pathway. Most single-case authorization requests for accelerated TMS are denied. Insurance companies are not yet systematically covering these protocols, and a request is not a guarantee or even a likelihood of approval. We will never ask you to delay treatment or hold a spot on the assumption that authorization will come through.
It is worth attempting in the right circumstances. If your clinical history is strong, if you've documented prior treatment failures, and if there is a clear medical rationale for the accelerated format over traditional TMS, we will put together the strongest possible case and submit it on your behalf. The published evidence behind the SAINT protocol and the ONE-D study is compelling, and some insurers respond to it.
If single-case authorization is something you want to explore, bring it up during your consultation. We'll review your history, give you an honest assessment of whether your situation is a reasonable candidate for the request, and handle the submission process if we decide it's worth pursuing together.
The bottom line
Insurance covers traditional TMS for most patients with depression who meet their plan's criteria. That coverage is real, and for some patients it's the right path.
But "covered by insurance" doesn't mean free, doesn't mean simple, and doesn't mean most effective. The true out-of-pocket cost of a traditional TMS course is often higher than patients expect, the administrative process is often more burdensome, and the published efficacy data for accelerated protocols is substantially stronger.
The honest recommendation: do the math specific to your plan before assuming the insurance route is the obvious choice. We'll help you do that math in a free consultation.
Out-of-pocket costs vary significantly by insurance plan, deductible status, coinsurance rate, and individual circumstances. The figures in this article are illustrative examples based on common plan structures, not guarantees of what you will pay. Always verify your specific benefits before making a financial decision.
